Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1991
05/07/1991CA1283917C Amino acid derivatives having anti-tumor activity and compositions containing them
05/07/1991CA1283914C Derivative of benzoquinonylphenyl alkanoic acid amide
05/07/1991CA1283910C Histamine h _antagonists
05/07/1991CA1283906C .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
05/07/1991CA1283905C Cephalosporin derivatives, processes for their preparation and antibacterial agents
05/07/1991CA1283860C Anti-asthmatic composition and method using 5,8,11,14- eicosatetraenoic acid
05/07/1991CA1283859C Penicillamine for treating immune damaging illnesses
05/07/1991CA1283858C Use of manoalide and its derivatives for modifying calcium hemostasis
05/07/1991CA1283855C Non-absorbable gastrointestinal medicament provided for treating the two levels of the digestive track at the same time
05/07/1991CA1283851C Foamable biocide composition
05/04/1991WO1991006316A1 Reduced-protein subunit vaccine for swine dysentery
05/03/1991WO1991006529A1 Glutamic and aspartic acid derivatives with antigastrin activity and a method for their preparation
05/03/1991WO1991006322A1 Magnetocontrollable carrier with physiologically active substance and method for making said carrier
05/03/1991CA2067569A1 Glutamic and aspartic acid derivatives with antigastrin activity and a method for their preparation
05/03/1991CA2045504A1 Magnetically controlled carrier with physiologically active agent and process for preparing thereof
05/03/1991CA2029216A1 Process of producing modified superoxide dismutase
05/03/1991CA2029057A1 Antithrombotic iso- and heterocyclic phenylsulphonamides
05/02/1991WO1991005867A1 Erythropoietin isoforms
05/02/1991WO1991005824A1 Anti-cancer compounds
05/02/1991WO1991005776A1 3-aryl oxazolidinones and their preparation and use
05/02/1991WO1991005775A1 Aryl-3 oxazolidinones and their preparation and use
05/02/1991WO1991005774A1 3-aryl oxazolidinones and their preparation and use
05/02/1991WO1991005772A1 Novel dihydro-1,2 oxo-2 quinoxaline derivates, their preparation and their application in therapeutics
05/02/1991WO1991005761A1 Treatment of hiv infections and compounds useful therein
05/02/1991WO1991005757A1 Lipoxygenase inhibitors
05/02/1991WO1991005560A1 PROTECTION FROM SHOCK SUBSEQUENT TO INJURY BY DOUBLE-STRANDED RNAs
05/02/1991WO1991005559A1 Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction
05/02/1991WO1991005553A1 Use of d-propranolol against sexually transmitted bacteria
05/02/1991WO1991005550A1 Medicament for the treatment of cryptosporidiosis
05/02/1991WO1991005549A1 Benzoheterocyclic compounds
05/02/1991WO1991005542A1 Ultraviolet radiation screening drops for the eyes
05/02/1991WO1991005538A2 Thiazolidine derivatives for the treatment of hypertension
05/02/1991WO1991005537A1 Method of accelerating wound and ulcer healing and treating periodontal disease
05/02/1991EP0425450A2 Maltodextrin/defoaming composition combinate
05/02/1991EP0425443A1 Injectable antiparasitic agent
05/02/1991EP0425373A1 Pharmaceutical and cosmetic composition containing cross-linked poly-beta-alamine spheres impregnated by lipophilic substances
05/02/1991EP0425362A2 Furosemide salts, process for their preparation, their use as medicines and pharmaceutical compositions containing them
05/02/1991EP0425298A2 Sustained-release preparation of basic medical agent hydrochloride
05/02/1991EP0425283A2 Novel triazolyl hydrazide derivatives and process for their preparation
05/02/1991EP0425282A2 Triazolo derivatives and process for their preparation
05/02/1991EP0425235A2 Cytotoxic agents comprising maytansinoids and their therapeutic use
05/02/1991EP0425212A2 Cyclic anti-aggregatory peptides
05/02/1991EP0425211A1 Substituted 5-((tetrazolyl)alkenyl)-imidazoles
05/02/1991EP0425209A2 Naphthyloxazolidone derivatives
05/02/1991EP0425134A1 Condensed pyrrolo derivatives, process for their preparation and pharmaceutical compositions containing them
05/02/1991EP0425109A2 3-Substituted-2-oxindole derivatives as inhibitors of interleukin-1 biosynthesis
05/02/1991EP0425066A1 Crystalline 2-0-alpha-D-glucopyranosyl-L-ascorbic acid, and its preparation and uses
05/02/1991EP0425019A1 Methods and compositions employing certain lysozymes and endoglycosidases
05/02/1991EP0425002A1 Oral compositions
05/02/1991EP0424954A1 Pharmaceutical composition for treatment of osteoporosis
05/02/1991EP0424929A1 Isoquinolone derivatives, their production and use
05/02/1991EP0424901A1 Dihydropyridine derivatives and pharmaceutical compositions
05/02/1991EP0424899A2 Novel anthracycline glycoside derivatives and preparing method thereof
05/02/1991EP0424851A1 Quinolone compounds and a process for their preparation
05/02/1991EP0424850A1 Quinolone compounds and a process for their preparation
05/02/1991EP0424848A2 Aminopyridinylaminophenols and related compounds, a process and intermediates for their preparation and their use as medicaments
05/02/1991EP0424832A2 Carbapenem compounds
05/02/1991EP0424802A2 Tricyclic quinoline antineoplastic agents
05/02/1991EP0424722A2 Substituted (quinolin-2-yl-methoxy)phenyl-thioureas
05/02/1991EP0424706A1 Chewable or suckable pharmaceutical form, process for its preparation and its use
05/02/1991EP0424553A1 Substituted phenoxy alkanols for treatment of contact hypersensitivity
05/02/1991EP0424543A1 New s-adenosylmethionine derivative
05/02/1991EP0424541A1 3-halogeno-2,3-diphenylacrylaldehyde derivative, method of production thereof and curing agent for hyperlipidemia
05/02/1991EP0424528A1 Phenylalkanoylamine derivatives, process for their preparation, and their uses
05/02/1991EP0424525A1 Novel amines and their use
05/02/1991EP0424484A1 Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection.
05/02/1991EP0424386A1 Device for site directed neovascularization and method for same
05/02/1991EP0424385A1 Lipophilic polyamines useful for treating hypercholesterolemia
05/02/1991EP0211928B1 Piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain
05/02/1991DE3938227C1 Oral antiinflammatory and analgetic pharmaceutical compsn. - comprises magnesium ibuprofen dissolved in mixt. of water, propane-1,2-diol and glycerol
05/02/1991DE3936328A1 Pharmazeutische praeparate Pharmaceutical products
05/02/1991DE3935580A1 Use of 1-octadecyl-2-methyl-glycero-3-phospho:choline - for treating immune infections e.g. HIV
05/02/1991CA2028622A1 11-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-–-reductase
05/02/1991CA2027935A1 Imidazo [4,5-b] quinolinyloxyalkanoic acid amides with enhanced water solubility
05/02/1991CA2026792A1 (6,7-dihydro-5h-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1h-benzotriazole derivatives
05/01/1991WO1991006863A1 Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
05/01/1991WO1991006310A1 Liposomal compositions
05/01/1991CN1051042A Process for preparing derivatives substituted in position 15 of 20,21 dinoreburnamenine
05/01/1991CN1051041A Antimuscarinic bronchodilators
05/01/1991CN1051039A W-phenoxy-heterocyclic compounds
05/01/1991CN1051038A Benzoheterocyclic compounds
05/01/1991CN1051036A Treatment of hiv infections and compounds useful therein
05/01/1991CN1012501B Quinolonecarboxylic acid derivatives and their preparation
05/01/1991CN1012500B Process for the preparation of arythydroxamtes
05/01/1991CN1012499B Compounds related to antibiotic tan-749 and their production
05/01/1991CN1012498B Process for n-(2'amino phenyl)-benzamide derivative and its drug composition
05/01/1991CA2069313A1 Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
05/01/1991CA2066698A1 Liposomal compositions
05/01/1991CA2028986A1 Application of n-methy (pyridyl-3)-2 tetrahydrothiopyrannecarbothioamide-2 oxyd-1 to the preparation of medications for treatment of coronary failure
05/01/1991CA2028985A1 Process for the preparation of (pyridyl-3)-2 tetrahydrothiopyranecarbothioamide-2-oxydes-1-(1r,2r), (pyridyl-3)-2 tetrahydrothiopyranecarbothioamide-2-oxydes-1-(1r,2r) thus obtained and pharmaceutical compositions containing the
05/01/1991CA2028880A1 Condensed imidazole derivatives and processes for preparation thereof
05/01/1991CA2028798A1 Benzylpyrrolidine derivatives as dopamine agonists
05/01/1991CA2028764A1 1-(4-aminophenyl)-2-piperidinopropanone derivatives, preparation process and use in therapeutics
05/01/1991CA2028763A1 24-and 25-substituted avermectin and milbemycin derivatives
05/01/1991CA2028758A1 Use of a benzodiazepine and a phenylpyrrylketone derivative
05/01/1991CA2028730A1 1-8 benzonaphtyridine derivatives, preparation and compositions thereof
05/01/1991CA2028709A1 Use of derivatives of chitin soluble in aqueous solutions for preventing adhesions
05/01/1991CA2028668A1 Compounds
05/01/1991CA2028621A1 Antithrombotic substituted cycloalkano[b]dihydroindole- and -indole-sulphonamides
05/01/1991CA2028604A1 Injectable formulation for lipophilic drugs
1 ... 7351 7352 7353 7354 7355 7356 7357 7358 7359 7360 7361 7362 7363 7364 7365 7366 7367 7368 7369 7370 7371 ... 7860